Company Evogene Ltd. TEL AVIV STOCK EXCHANGE
Equities
EVGN
IL0011050551
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Agriculture
67.2
%
| 1 | 52.3 % | 4 | 67.2 % | +332.76% |
Industrial Applications
19.1
%
| 0 | 4.3 % | 1 | 19.1 % | +1,393.06% |
Human Health
8.6
%
| 1 | 30.6 % | 0 | 8.6 % | -5.07% |
Unallocated
5.1
%
| 0 | 12.8 % | 0 | 5.1 % | +34.11% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
65.0
%
| 1 | 51.0 % | 4 | 65.0 % | +329.15% |
Others
19.0
%
| 0 | 4.0 % | 1 | 19.0 % | +1,499.40% |
Israel
16.0
%
| 1 | 45.0 % | 1 | 16.0 % | +19.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-12-31 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 22-03-31 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 04-12-31 |
Eyal Ronen
PRN | Corporate Officer/Principal | - | 22-05-31 |
Sassi Masliah
PRN | Corporate Officer/Principal | - | 10-12-31 |
Human Resources Officer | - | 14-12-31 | |
Nir Arbel
PRN | Corporate Officer/Principal | - | 21-07-31 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 21-11-16 |
Sarit Firon
CHM | Chairman | 58 | 16-08-10 |
Leon Recanati
BRD | Director/Board Member | 76 | 05-04-30 |
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-12-31 |
Oded Shoseyov
BRD | Director/Board Member | 68 | 18-10-31 |
Nir Nimrodi
BRD | Director/Board Member | 55 | 22-08-31 |
Adrian Percy
BRD | Director/Board Member | 59 | 19-02-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,584,888 | 49,746,029 ( 98.34 %) | 0 | 98.34 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |